Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
Nabil Adra, Costantine Albany, Mary J. Brames, Somer Case-Eads, Cynthia S. Johnson, Ziyue Liu, Christopher A. Fausel, Timothy Breen, Nasser H. Hanna, Ralph J. Hauke, Joel Picus, Lawrence H. Einhorn
Dive into the research topics of 'Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study'. Together they form a unique fingerprint.